General
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas
Oxford University and AstraZeneca’s potential COVID-19 vaccine produced a strong immune response in older adults, newly published data has showed, with researchers expecting to release late-stage trial results by Christmas.
Key points:
- Late stage Oxford-AstraZeneca trials have shown it develops antibody and T-cell responses in elderly patients
- Rival drugmakers Pfizer-BioNTech and Moderna have recently pushed ahead in the race for a COVID vaccine
- Researchers report no serious side effects from the Oxford-AstraZeneca vaccine
The data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust…
-
General12 hours agoChildren ‘traumatised’ as wheel flies off speedway car into crowd at Avalon Raceway
-
General20 hours agoFriends of Belgian tourist Celine Cremer missing near Tasmanian waterfall walk renew search
-
Noosa News21 hours agoMatildas midfielder Tameka Yallop requires surgery, all but ruling her out of home AFC Asian Cup
-
General23 hours agoForget “the rules”, pollies should get their snouts out of the travel trough